Digital App for Speech & Health Monitoring
1 other identifier
observational
150
1 country
1
Brief Summary
Many people living with neurodegenerative conditions like dementia, motor neuron disease (MND), multiple sclerosis (MS), and Parkinson's disease (PD), suffer from speech problems. Using common digital technologies such as smartphone apps, the investigators can record and analyse speech in detail to provide new information for people living with these conditions, researchers, and healthcare professionals. This study will investigate the use of these digital speech recordings to help diagnose and monitor these conditions. To take part, participants will have either a diagnosis of dementia, motor neuron disease, Parkinson's disease or Multiple Sclerosis, OR they will have no diagnosis of a neurological condition. Researchers will compare people with a diagnosis of a Neurological condition to those without.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 9, 2024
CompletedFirst Posted
Study publicly available on registry
June 10, 2024
CompletedStudy Start
First participant enrolled
July 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
September 18, 2025
September 1, 2025
1.9 years
February 9, 2024
September 17, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Primary outcome measures
Area under the curve (AUC) of the receiver operating characteristic (ROC) curve for each of the 4 binary classifiers distinguishing between a disease-positive group and a healthy control group.
24 months
Secondary Outcomes (2)
Secondary outcome measure
24 months
Secondary outcome measure
24 months
Study Arms (5)
Carers/Realtives/ Healthy - No Diagnosis of a Neurodegenerative Disorder
Motor Neuron Disease
Multiple Sclerosis
Dementia
Parkinson's Disease
Eligibility Criteria
Participants with Neurodegenerative Disorders and their relatives or carers without a diagnosis of a Neurodegenerative disorder.
You may qualify if:
- A person with a diagnosis of Motor Neuron Disease, Dementia, Multiple Sclerosis, or Parkinson's Disease.
- A relative or carer of the above who does not report to have a neurological condition.
- A healthy volunteer who does not report to have a neurological condition.
You may not qualify if:
- Age \<16 years
- Significant and uncorrected visual or hearing impairment (precluding use of the App).
- Lack capacity to consent to project due to cognitive impairment (precluding understanding of the study and use of the App).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Edinburghlead
- NHS Lothiancollaborator
Study Sites (1)
NHS Lothian
Edinburgh, United Kingdom
Related Publications (1)
Tam J, Weaver C, Ihenacho A, Newton J, Virgo B, Barrett S, Neale J, Perry D, Smith A, Chandran S, Watts O, Pal S; DASH Consortium. Digital App for Speech and Health Monitoring Study (DASH): protocol for a prospective longitudinal case-control observational study for developing speech datasets in neurodegenerative disorders and dementia. BMJ Open. 2025 Dec 5;15(12):e100222. doi: 10.1136/bmjopen-2025-100222.
PMID: 41360452DERIVED
Biospecimen
Participants can additionally and optionally consent for blood samples to be obtained during the study. These samples will be collected and stored with the intention of exploring emerging blood-based biomarkers.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Suvankar Pal, Prof
University of Edinburgh
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 9, 2024
First Posted
June 10, 2024
Study Start
July 12, 2024
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
September 18, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share